Trial NCT03567616

View at ClinicalTrials.gov 
Org. Study IDs: M16-085
Secondary IDs: 2017-004232-11

Last trial update was posted on 2021-06-30

MeSH Interventions

Dexamethasone Pomalidomide Venetoclax

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Following results of the primary progression-free survival analysis from Study NCT02755597, company-sponsored MM studies were placed on partial clinical hold (PCH). Sponsor did not pursue release of the PCH for this study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID